Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Lee

Showing results (191-200 of 199) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 199 results.
Nature Communications|November 26, 2025
Distinct brain alterations and neurodegenerative processes in cognitive impairment associated with post-acute sequelae of COVID-19Dayoung Seo, Yangsean Choi, Eunseon Jeong, et al.
Journal of Korean Medical Science|January 24, 2018
Hospital-based Influenza Morbidity and Mortality (HIMM) Surveillance for A/H7N9 Influenza Virus Infection in Returning TravelersJoon Young Song, Ji Yun Noh, Jacob Lee, et al.
Vaccine|March 14, 2022
Persistent serotype 3 and 19A invasive pneumococcal diseases in adults in vaccine era: Serotype-dependent difference in ceftriaxone susceptibilityJin Gu Yoon, A-Yeung Jang, Min Ja Kim, et al.
Vaccine|July 31, 2018
Significant circulation of influenza B viruses mismatching the recommended vaccine-lineage in South Korea, 2007-2014Ji Yun Noh, Won Suk Choi, Joon Young Song, et al.
Infection & Chemotherapy|January 21, 2016
Middle East Respiratory Syndrome Infection Control and Prevention Guideline for Healthcare FacilitiesJin Yong Kim, Joon Young Song, Young Kyung Yoon, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 10, 2025
Safety and immunogenicity of a homologous booster dose of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: 12 months follow-up result of an open-label, nonrandomized extension of a phase 1/2 trialJoon Young Song, Won Suk Choi, Jung Yeon Heo, et al.
Eclinicalmedicine|July 26, 2022
Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trialJoon Young Song, Won Suk Choi, Jung Yeon Heo, et al.
Eclinicalmedicine|September 15, 2023
Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trialJoon Young Song, Won Suk Choi, Jung Yeon Heo, et al.
Infection & Chemotherapy|July 20, 2016
Clinical Presentation and Outcomes of Middle East Respiratory Syndrome in the Republic of KoreaWon Suk Choi, Cheol-In Kang, Yonjae Kim, et al.
Pageof 20

Showing results (191-200 of 199) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 199 results.
Nature Communications|November 26, 2025
Distinct brain alterations and neurodegenerative processes in cognitive impairment associated with post-acute sequelae of COVID-19Dayoung Seo, Yangsean Choi, Eunseon Jeong, et al.
Journal of Korean Medical Science|January 24, 2018
Hospital-based Influenza Morbidity and Mortality (HIMM) Surveillance for A/H7N9 Influenza Virus Infection in Returning TravelersJoon Young Song, Ji Yun Noh, Jacob Lee, et al.
Vaccine|March 14, 2022
Persistent serotype 3 and 19A invasive pneumococcal diseases in adults in vaccine era: Serotype-dependent difference in ceftriaxone susceptibilityJin Gu Yoon, A-Yeung Jang, Min Ja Kim, et al.
Vaccine|July 31, 2018
Significant circulation of influenza B viruses mismatching the recommended vaccine-lineage in South Korea, 2007-2014Ji Yun Noh, Won Suk Choi, Joon Young Song, et al.
Infection & Chemotherapy|January 21, 2016
Middle East Respiratory Syndrome Infection Control and Prevention Guideline for Healthcare FacilitiesJin Yong Kim, Joon Young Song, Young Kyung Yoon, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 10, 2025
Safety and immunogenicity of a homologous booster dose of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: 12 months follow-up result of an open-label, nonrandomized extension of a phase 1/2 trialJoon Young Song, Won Suk Choi, Jung Yeon Heo, et al.
Eclinicalmedicine|July 26, 2022
Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trialJoon Young Song, Won Suk Choi, Jung Yeon Heo, et al.
Eclinicalmedicine|September 15, 2023
Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trialJoon Young Song, Won Suk Choi, Jung Yeon Heo, et al.
Infection & Chemotherapy|July 20, 2016
Clinical Presentation and Outcomes of Middle East Respiratory Syndrome in the Republic of KoreaWon Suk Choi, Cheol-In Kang, Yonjae Kim, et al.
Pageof 20